...
首页> 外文期刊>Prion >Aggregated proteins in schizophrenia and other chronic mental diseases DISC1opathies
【24h】

Aggregated proteins in schizophrenia and other chronic mental diseases DISC1opathies

机译:精神分裂症和其他慢性精神疾病DISC1的聚集蛋白

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chronic mental diseases (CMD) like the schizophrenias are progressive diseases of heterogenous but poorly understood biological origin. An imbalance in proteostasis is a hallmark of dysfunctional neurons, leading to impaired clearance and abnormal deposition of protein aggregates. Thus, it can be hypothesized that unbalanced proteostasis in such neurons may also lead to protein aggregates in schizophrenia. These protein aggregates, however, would be more subtle then in the classical neurodegenerative diseases and as such have not yet been detected. The DISC1 (Disrupted-in-schizophrenia 1) gene is considered among the most promising candidate genes for CMD having been identified as linked to CMD in a Scottish pedigree and having since been found to associate to various phenotypes of CMD. We have recently demonstrated increased insoluble DISC1 protein in the cingular cortex in approximately 20% of cases of CMD within the widely used Stanley Medical Research Institute Consortium Collection. Surprisingly, in vitro, DISC1 aggregates were cell-invasive, i.e., purified aggresomes or recombinant DISC1 fragments where internalized at an efficiency comparable to that of α-synuclein. Intracellular DISC1 aggresomes acquired gain-of-function properties in recruiting otherwise soluble proteins such as the candidate schizophrenia protein dysbindin. Disease-associated DISC1 polymorphism S704C led to a higher oligomerization tendency of DISC1. These findings justify classification of DISC1-dependent brain disorders as protein conformational disorders which we have tentatively termed DISC1opathies. The notion of disturbed proteostasis and protein aggregation as a mechanism of mental diseases is thus emerging. The yet unidentified form of neuronal impairment in CMD is more subtle than in the classical neurodegenerative diseases without leading to massive cell death and as such present a different kind of neuronal dysfunctionality, eventually confined to highly selective CNS subpopulations.
机译:像精神分裂症这样的慢性精神疾病(CMD)是异质性但生物学来源知之甚少的进行性疾病。蛋白质稳态失衡是神经元功能失调的标志,导致清除率降低和蛋白质聚集体异常沉积。因此,可以假设这种神经元中的蛋白平衡失衡也可能导致精神分裂症中的蛋白质聚集。然而,这些蛋白质聚集体比经典的神经退行性疾病要微妙得多,因此尚未被发现。 DISC1(精神分裂症1)基因被认为是最有希望的CMD候选基因之一,在苏格兰血统书中已将其鉴定为与CMD相关联,并已发现与CMD的各种表型相关。我们最近证明,在广泛使用的斯坦利医学研究所联合体集合中,大约20%的CMD病例的扣带皮层中的不溶DISC1蛋白增加。出人意料的是,在体外,DISC1聚集体是细胞侵入性的,即纯化的聚集体或重组DISC1片段,其内在化的效率与α-突触核蛋白相当。细胞内DISC1聚集体在募集其他可溶性蛋白(例如候选精神分裂症蛋白dysbindin)中获得了功能获得特性。与疾病相关的DISC1多态性S704C导致DISC1的更高的低聚趋势。这些发现证明将DISC1依赖性脑部疾病分类为蛋白质构象性疾病,我们将其暂时称为DISC1opathies。因此,涌现的蛋白质不稳定和蛋白质聚集是精神疾病的一种机制。与经典的神经退行性疾病相比,CMD中神经元损伤的形式尚未查明,却没有导致大量细胞死亡,因此呈现出另一种神经元功能障碍,最终仅限于高度选择性的CNS亚群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号